These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18038462)

  • 41. A cis-acting regulatory variant in the IL2RA locus.
    Qu HQ; Verlaan DJ; Ge B; Lu Y; Lam KC; Grabs R; Harmsen E; Hudson TJ; Hakonarson H; Pastinen T; Polychronakos C
    J Immunol; 2009 Oct; 183(8):5158-62. PubMed ID: 19794070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.
    Márquez A; Orozco G; Martínez A; Palomino-Morales R; Fernández-Arquero M; Mendoza JL; Taxonera C; Díaz-Rubio M; Gómez-García M; Nieto A; López-Nevot MA; de la Concha EG; Martín J; Urcelay E
    Am J Gastroenterol; 2009 Aug; 104(8):1968-75. PubMed ID: 19471255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CASP-9: A susceptibility locus for multiple sclerosis in Italy.
    Andreoli V; Trecroci F; La Russa A; Valentino P; Condino F; Latorre V; Nisticò R; Pirritano D; Del Giudice F; Canino M; Cittadella R; Quattrone A
    J Neuroimmunol; 2009 May; 210(1-2):100-3. PubMed ID: 19359048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
    Kantarci OH; Hebrink DD; Schaefer-Klein J; Sun Y; Achenbach S; Atkinson EJ; Heggarty S; Cotleur AC; de Andrade M; Vandenbroeck K; Pelfrey CM; Weinshenker BG
    Arch Neurol; 2008 Mar; 65(3):349-57. PubMed ID: 18332247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis].
    Zettl UK; Goertsches RH
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S64-8. PubMed ID: 19685398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
    Goris A; Dobosi R; Boonen S; Nagels G; Dubois B
    J Neuroimmunol; 2009 May; 210(1-2):113-5. PubMed ID: 19304328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.
    Márquez A; Cénit MC; Núñez C; Mendoza JL; Taxonera C; Díaz-Rubio M; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
    Genes Immun; 2009 Oct; 10(7):631-5. PubMed ID: 19657358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of the PPARgamma gene polymorphism Pro12Ala with delayed onset of multiple sclerosis.
    Klotz L; Schmidt S; Heun R; Klockgether T; Kölsch H
    Neurosci Lett; 2009 Jan; 449(1):81-3. PubMed ID: 18977277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic regulation of CTLA4 and multiple sclerosis.
    Palacios R; Comas D; Elorza J; Villoslada P
    J Neuroimmunol; 2008 Oct; 203(1):108-15. PubMed ID: 18691768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mendelian multiple sclerosis triggers mechanistic rethink.
    Fyfe I
    Nat Rev Neurol; 2019 Aug; 15(8):436. PubMed ID: 31190009
    [No Abstract]   [Full Text] [Related]  

  • 52. No evidence for association of the protein kinase C alpha gene with multiple sclerosis.
    Ban M; Maranian M; Yeo TW; Gray J; Compston A; Sawcer S
    J Neurol; 2005 May; 252(5):619-20. PubMed ID: 15742114
    [No Abstract]   [Full Text] [Related]  

  • 53. [A case report of severe combined immunodeficiency caused by IL7R gene deficiency].
    Zhang XQ; Song XX; Tang WG; Qiu MH; Jin ZQ
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):1013-1015. PubMed ID: 33256325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial incidence of multiple sclerosis.
    POLVAN N
    Wien Z Nervenheilkd Grenzgeb; 1958; 15(1-4):224-8. PubMed ID: 13604302
    [No Abstract]   [Full Text] [Related]  

  • 55. Prime time for multiple sclerosis genetics.
    Bradbury J
    Lancet Neurol; 2005 Nov; 4(11):698-9. PubMed ID: 16265789
    [No Abstract]   [Full Text] [Related]  

  • 56. Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.
    Babron MC; Perdry H; Handel AE; Ramagopalan SV; Damotte V; Fontaine B; Müller-Myhsok B; Ebers GC; Clerget-Darpoux F
    Eur J Hum Genet; 2012 Mar; 20(3):321-5. PubMed ID: 22085902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis.
    Shokrgozar MA; Sarial S; Amirzargar A; Shokri F; Rezaei N; Arjang Z; Radfar J; Yousefi-Behzadi M; Ali Sahraian M; Lotfi J
    J Clin Immunol; 2009 Nov; 29(6):747-51. PubMed ID: 19543959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).
    Alcina A; Fedetz M; Ndagire D; Fernández O; Leyva L; Guerrero M; Abad-Grau MM; Arnal C; Delgado C; Lucas M; Izquierdo G; Matesanz F
    PLoS One; 2009; 4(1):e4137. PubMed ID: 19125193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomewide study of multiple sclerosis.
    Matesanz F; Fernández O; Alcina A
    N Engl J Med; 2007 Nov; 357(21):2200; author reply 2200-1. PubMed ID: 18038462
    [No Abstract]   [Full Text] [Related]  

  • 60. Genomewide study of multiple sclerosis.
    Ramagopalan SV; Anderson C; Sadovnick AD; Ebers GC
    N Engl J Med; 2007 Nov; 357(21):2199-200; author reply 2200-1. PubMed ID: 18032773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.